Application of TROAP in preparation of renal cell carcinoma prognosis product and therapeutic drug

一种肾细胞癌、治疗药物的技术,应用在生物医药领域,能够解决五年生存率不足20%、患者远处转移、诊断和预后缺乏等问题,达到提高早期预警能力及后续治疗效果、促进细胞增殖、抑制凋亡的效果

Active Publication Date: 2021-11-26
CHANGZHOU NO 2 PEOPLES HOSPITAL +1
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, surgery is the main treatment for kidney cancer, but many patients have already developed distant metastasis when they are diagnosed with kidney cancer, and their five-year survival rate is less than 20%.
[0006] Although many studies have shown that TROAP is involved in the occurrence and development of tumors, its role in renal cell carcinoma has not been reported in the literature so far. Whether TROAP can be used as a marker for the diagnosis and prognosis of renal cell carcinoma still lacks corresponding research support; In addition, the role of TROAP in the effect of renal cell carcinoma and the corresponding molecular mechanism are still unclear

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0035] Correlation experiment between TROAP and renal cancer.

[0036] The protein expression level of TROAP in 20 pairs of renal cancer and corresponding renal normal tissues was detected by immunohistochemistry, and the results showed that TROAP was significantly highly expressed in renal cancer tissues; subsequent subgroup analysis of renal cancer grades indicated that as the grade increased, the tumor The expression of TROAP in tissues also showed an increasing trend, and the results were statistically different ( figure 1 ), the results suggest that TROAP may be closely related to the occurrence and development of RCC.

[0037] see figure 1 .Immunohistochemical verification of the expression of TROAP in clear cell renal cell carcinoma.

[0038] Immunohistochemical (IHS) results showed:

[0039] A.B.C.TROAP was highly expressed in renal cancer tissues, and there was a statistically significant difference (P<0.001);

[0040] D-H. The higher the clinical grade of renal c...

Embodiment 2

[0042] In vitro and in vivo experiments showed that knocking down TROAP could inhibit the proliferation, migration and invasion of renal cancer cells.

[0043] Because TROAP is closely related to the clinical practice of renal cell carcinoma, its function in the progression of renal cell carcinoma was further explored. The commonly used kidney cancer cell lines 786-0 and ACHN were selected, and the lentivirus interference technology was used to knock down TROAP ( figure 2 ), functional experiments include MTT cell proliferation, apoptosis, cell scratch healing and Transwell invasion in vitro. Knockdown of TROAP can significantly inhibit the growth of 786-0 and ACHN cells ( image 3 ); Knockdown of TROAP significantly increased the percentage of apoptosis in 786-0 and ACHN cells ( Figure 4 ); Knockdown of TROAP significantly reduced the scratch healing ability of 786-0 and ACHN cells ( Figure 5 ); Knockdown of TROAP significantly inhibited the invasion ability of 786-0 an...

Embodiment 3

[0052] In vivo subcutaneous tumor formation experiment in nude mice.

[0053] The present invention carried out subcutaneous tumor formation experiments in nude mice in vivo, and subcutaneously inoculated ACHN cells. The results showed that the tumor growth of the TROAP knockdown group was slow, and the final tumor volume was significantly smaller than that of the control group ( Figure 7 ).

[0054] see Figure 7 . Subcutaneous tumor growth experiment in nude mice. Subcutaneous tumor growth was inhibited after TROAP interference.

[0055] A: 10 pairs of nude mice and their subcutaneous tumors.

[0056] B: The growth curve of subcutaneous tumors in nude mice, showing that the growth of subcutaneous tumors in the TROAP interference group was significantly inhibited.

[0057] C: The average volume of subcutaneous tumors in nude mice after 4 weeks, showing that the volume of the TROAP interference group was significantly lower than that of the control group.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the field of biological medicine, and relates to application of TROAP in preparation of renal cell carcinoma prognosis products and therapeutic drugs. Experiments find and prove that the TROAP gene can promote proliferation, migration and invasion of renal carcinoma cells and inhibit apoptosis at the same time, and is a very important marker for renal carcinoma progression. On the basis, the TROAP gene is used as a screened molecular marker, the prognosis condition of a renal cell carcinoma patient is judged by detecting the expression level of the TROAP, clinical treatment is guided through a prognosis model, and the application has important practical application value for evaluating the prognosis of the patient and guiding the individualized treatment of the patient. Meanwhile, the ROAP gene serves as a targeted drug development action target, a new inhibitor and a new drug development target are provided for the renal clear cell carcinoma, especially metastatic clear cell carcinoma, and the early warning capacity and the subsequent treatment effect on the patients of the type are improved.

Description

technical field [0001] The invention relates to the field of biomedicine, in particular to the use of TROAP in the preparation of prognostic products and therapeutic drugs for renal cell carcinoma. Background technique [0002] Renal cell carcinoma (RCC), referred to as renal cell carcinoma, is one of the common malignant tumors of the urinary system, accounting for 2%-3% of adult malignant tumors, of which clear cell renal cell carcinoma accounts for about 80%. , ccRCC)[1]. At present, surgery is the main treatment for renal cancer, but many patients have already developed distant metastasis when they are diagnosed with renal cancer, and their five-year survival rate is less than 20%. Localized RCC patients still have a recurrence rate of 20%-40% after surgical treatment [2]. In addition, renal cancer is not sensitive to radiotherapy and chemotherapy, and patients with advanced renal cancer are prone to drug resistance after using molecular targeted drugs, which reduces t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/6886C12Q1/6869A61K45/00A61P35/00A61P13/12
CPCC12Q1/6886C12Q1/6869A61K45/00A61P35/00A61P13/12C12Q2600/158C12Q2600/118C12Q2600/106C12Q2535/122
Inventor 左立史晓凯张力峰高生林糜远源
Owner CHANGZHOU NO 2 PEOPLES HOSPITAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products